




Searching News Database: Thrombin
HSMN NewsFeed - 12 Aug 2021
Medcura raises $7.4 Million to Expand FDA-Approved Line of Hemostatic and Wound Treatment Products
Medcura raises $7.4 Million to Expand FDA-Approved Line of Hemostatic and Wound Treatment Products
HSMN NewsFeed - 24 Feb 2021
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
HSMN NewsFeed - 16 Nov 2017
FDA Approves New Treatment to Prevent Bleeding in Certain Patients with Hemophilia A
FDA Approves New Treatment to Prevent Bleeding in Certain Patients with Hemophilia A
HSMN NewsFeed - 22 Dec 2016
Genentech’s Emicizumab for Hemophilia A Meets Primary Endpoint in Phase III Study
Genentech’s Emicizumab for Hemophilia A Meets Primary Endpoint in Phase III Study
HSMN NewsFeed - 9 Jul 2015
The Medicines Company Authorizes Generic Launch of ANGIOMAX(R) (bivalirudin)
The Medicines Company Authorizes Generic Launch of ANGIOMAX(R) (bivalirudin)
HSMN NewsFeed - 23 Apr 2014
The Medicines Company Adds Novel, Approved, Surgical Sealant to Its Surgical Hemostasis Portfolio
The Medicines Company Adds Novel, Approved, Surgical Sealant to Its Surgical Hemostasis Portfolio
HSMN NewsFeed - 13 Jan 2014
Alnylam and Genzyme Form Transformational Alliance for RNAi Therapeutics as Genetic Medicines
Alnylam and Genzyme Form Transformational Alliance for RNAi Therapeutics as Genetic Medicines
HSMN NewsFeed - 15 May 2013
Bayer Initiates Phase III Trial of Stivarga(R) (regorafenib) Tablets in Patients with Advanced Liver Cancer
Bayer Initiates Phase III Trial of Stivarga(R) (regorafenib) Tablets in Patients with Advanced Liver Cancer
HSMN NewsFeed - 28 Feb 2013
CSL Behring Receives FDA Approval to Expand the Indication for Corifact(R)
CSL Behring Receives FDA Approval to Expand the Indication for Corifact(R)
HSMN NewsFeed - 8 Feb 2013
The Medicines Company and Bristol-Myers Squibb Begin Global Alliance for Recothrom(R)
The Medicines Company and Bristol-Myers Squibb Begin Global Alliance for Recothrom(R)
HSMN NewsFeed - 12 Dec 2012
The Medicines Company and Bristol-Myers Squibb Agree to Global Alliance for Recothrom(R)
The Medicines Company and Bristol-Myers Squibb Agree to Global Alliance for Recothrom(R)
HSMN NewsFeed - 28 Aug 2012
Latest European Heart Attack Treatment Guidelines Recommend Angiomax(R)/Angiox(R) (Bivalirudin) Over Heparin
Latest European Heart Attack Treatment Guidelines Recommend Angiomax(R)/Angiox(R) (Bivalirudin) Over Heparin
HSMN NewsFeed - 25 Oct 2011
Lilly Announces Withdrawal of Xigris(R) Following Recent Clinical Trial Results
Lilly Announces Withdrawal of Xigris(R) Following Recent Clinical Trial Results
HSMN NewsFeed - 12 Oct 2011
Onyx Pharmaceuticals and Bayer Healthcare Restructure Global Oncology Partnership
Onyx Pharmaceuticals and Bayer Healthcare Restructure Global Oncology Partnership
HSMN NewsFeed - 21 Sep 2011
Cytomedix Announces Publication of Data From Wound Outcomes Registry in the International Wound Journal
Cytomedix Announces Publication of Data From Wound Outcomes Registry in the International Wound Journal
HSMN NewsFeed - 31 Aug 2011
Baxter Announces FDA Approval of ARTISS Fibrin Sealant for Use in Face-Lift (Facial Rhytidectomy) Procedures
Baxter Announces FDA Approval of ARTISS Fibrin Sealant for Use in Face-Lift (Facial Rhytidectomy) Procedures
HSMN NewsFeed - 1 Jul 2011
Merck Receives Approval to Market GARDASIL(R), ZOLINZA(R) and CUBICIN(R) in Japan
Merck Receives Approval to Market GARDASIL(R), ZOLINZA(R) and CUBICIN(R) in Japan
HSMN NewsFeed - 1 Feb 2011
Atherotech Diagnostics Lab Taps Mize as Vice President of Regulatory Affairs
Atherotech Diagnostics Lab Taps Mize as Vice President of Regulatory Affairs
HSMN NewsFeed - 1 Dec 2010
Octapharma USA Focuses on Urgent Surgeries as FDA Approves octaplex(R) for Fast Track Development
Octapharma USA Focuses on Urgent Surgeries as FDA Approves octaplex(R) for Fast Track Development
HSMN NewsFeed - 16 Jun 2010
GTC Biotherapeutics Announces New $7 Million Financing, Company Restructuring and Management Changes
GTC Biotherapeutics Announces New $7 Million Financing, Company Restructuring and Management Changes
HSMN NewsFeed - 3 May 2010
FDA Approved VIMOVO(TM) for Arthritis Patients at Risk of Developing NSAID-Associated Gastric Ulcers
FDA Approved VIMOVO(TM) for Arthritis Patients at Risk of Developing NSAID-Associated Gastric Ulcers
HSMN NewsFeed - 26 Apr 2010
Osmetech plc Receives 510(k) Clearance for the eSensor(R) Thrombophilia Risk Test
Osmetech plc Receives 510(k) Clearance for the eSensor(R) Thrombophilia Risk Test
HSMN NewsFeed - 27 Nov 2009
Theravance Receives Complete Response Letter on the Telavancin NDA for the Treatment of Nosocomial Pneumonia
Theravance Receives Complete Response Letter on the Telavancin NDA for the Treatment of Nosocomial Pneumonia
HSMN NewsFeed - 5 Nov 2009
Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States
Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States
HSMN NewsFeed - 8 Jul 2009
GTC Biotherapeutics in-Licenses Recombinant Human Alpha-Fetoprotein from Merrimack Pharmaceuticals
GTC Biotherapeutics in-Licenses Recombinant Human Alpha-Fetoprotein from Merrimack Pharmaceuticals
HSMN NewsFeed - 10 Jun 2009
ZymoGenetics Appoints Eleanor L. Ramos, M.D. Senior Vice President and Chief Medical Officer
ZymoGenetics Appoints Eleanor L. Ramos, M.D. Senior Vice President and Chief Medical Officer
HSMN NewsFeed - 4 May 2009
AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
HSMN NewsFeed - 25 Feb 2009
ARCA biopharma Appoints Kathryn Falberg as Chief Financial Officer and Chief Operating Officer
ARCA biopharma Appoints Kathryn Falberg as Chief Financial Officer and Chief Operating Officer
HSMN NewsFeed - 23 Feb 2009
KAPIDEX(TM) (dexlansoprazole) delayed release capsules Now Available for the Treatment of GERD
KAPIDEX(TM) (dexlansoprazole) delayed release capsules Now Available for the Treatment of GERD
HSMN NewsFeed - 30 Jan 2009
FDA Approves KAPIDEX(TM) (Dexlansoprazole) Delayed Release Capsules for the Treatment of GERD
FDA Approves KAPIDEX(TM) (Dexlansoprazole) Delayed Release Capsules for the Treatment of GERD
HSMN NewsFeed - 24 Sep 2008
Nice Approves Pradaxa(R)*(Dabigatran Etexilate) - First New Oral Anticoagulant in the UK for Over 50 Years
Nice Approves Pradaxa(R)*(Dabigatran Etexilate) - First New Oral Anticoagulant in the UK for Over 50 Years
HSMN NewsFeed - 9 Sep 2008
ThermoGenesis Announces Distribution Agreement for Bone Marrow Stem Cell Device
ThermoGenesis Announces Distribution Agreement for Bone Marrow Stem Cell Device
HSMN NewsFeed - 26 Aug 2008
ACUITY 1-Year Sub-Analysis Published in Journal of the American College of Cardiology
ACUITY 1-Year Sub-Analysis Published in Journal of the American College of Cardiology
HSMN NewsFeed - 9 Jul 2008
Portola Completes $60 Million Financing to Advance Its Therapeutic Programs
Portola Completes $60 Million Financing to Advance Its Therapeutic Programs
HSMN NewsFeed - 23 Jun 2008
OVATION Pharmaceuticals to In-License ATryn(R) (antithrombin alfa) in the United States
OVATION Pharmaceuticals to In-License ATryn(R) (antithrombin alfa) in the United States
HSMN NewsFeed - 28 May 2008
The Medicines Company Receives FDA Review Letter for Angiomax Supplemental Filing
The Medicines Company Receives FDA Review Letter for Angiomax Supplemental Filing
HSMN NewsFeed - 27 May 2008
ZymoGenetics Announces FDA Approval of RECOTHROM(TM) 20,000-IU Vial Size and Co-Packaging with Spray Kit
ZymoGenetics Announces FDA Approval of RECOTHROM(TM) 20,000-IU Vial Size and Co-Packaging with Spray Kit
HSMN NewsFeed - 27 Mar 2008
Novel Oral Anticoagulant Pradaxa(R) (dabigatran etexilate) Approved by the European Commission
Novel Oral Anticoagulant Pradaxa(R) (dabigatran etexilate) Approved by the European Commission
HSMN NewsFeed - 20 Mar 2008
Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients
Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients
HSMN NewsFeed - 25 Jan 2008
Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium
Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium
HSMN NewsFeed - 14 Jan 2008
King Pharmaceuticals Reports FDA Approval of Revised Labeling Regarding Purity of THROMBIN-JMI(R)
King Pharmaceuticals Reports FDA Approval of Revised Labeling Regarding Purity of THROMBIN-JMI(R)
HSMN NewsFeed - 14 Jan 2008
Encysive Pharmaceuticals Launches THELIN (sitaxentan sodium) in Belgium and Luxembourg
Encysive Pharmaceuticals Launches THELIN (sitaxentan sodium) in Belgium and Luxembourg
HSMN NewsFeed - 10 Jan 2008
LFB Biotechnologies to Collaborate with GTC Biotherapeutics on Coagulation Factor IX Program
LFB Biotechnologies to Collaborate with GTC Biotherapeutics on Coagulation Factor IX Program
HSMN NewsFeed - 7 Jan 2008
Xeloda(R) Combination Therapy in Esophagogastric Cancer Highlighted in New England Journal of Medicine
Xeloda(R) Combination Therapy in Esophagogastric Cancer Highlighted in New England Journal of Medicine
HSMN NewsFeed - 4 Dec 2007
Journal of the American Medical Association (JAMA) Publishes One-Year ACUITY Trial Results
Journal of the American Medical Association (JAMA) Publishes One-Year ACUITY Trial Results
HSMN NewsFeed - 15 Nov 2007
Wyeth Receives FDA Approval of Protonix for Delayed-Release Oral Suspension
Wyeth Receives FDA Approval of Protonix for Delayed-Release Oral Suspension
HSMN NewsFeed - 24 Oct 2007
Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
HSMN NewsFeed - 9 Oct 2007
ThermoGenesis Announces 510(k) Clearance for AutoXpress(TM) Cord Blood Processing System
ThermoGenesis Announces 510(k) Clearance for AutoXpress(TM) Cord Blood Processing System
HSMN NewsFeed - 25 Sep 2007
Instrumentation Laboratory Receives FDA Clearance for HemosIL RecombiPlasTin 2G Assay
Instrumentation Laboratory Receives FDA Clearance for HemosIL RecombiPlasTin 2G Assay
HSMN NewsFeed - 13 Sep 2007
Encysive Pharmaceuticals Announces Launch of THELIN (sitaxentan sodium) in Spain
Encysive Pharmaceuticals Announces Launch of THELIN (sitaxentan sodium) in Spain
HSMN NewsFeed - 11 Sep 2007
Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
HSMN NewsFeed - 4 Sep 2007
GTC Obtains FDA Fast Track Designation for ATryn(R) and Permission to Submit a Rolling BLA
GTC Obtains FDA Fast Track Designation for ATryn(R) and Permission to Submit a Rolling BLA
HSMN NewsFeed - 22 Aug 2007
Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
HSMN NewsFeed - 7 Aug 2007
The Medicines Company Submits Angiomax(R) (Bivalirudin) sNDA to Expand Label to Include ACUITY Data
The Medicines Company Submits Angiomax(R) (Bivalirudin) sNDA to Expand Label to Include ACUITY Data
HSMN NewsFeed - 6 Aug 2007
Orthovita Receives CE Mark for VITAGEL(R) Surgical Hemostat and CELLPAKER(R) Plasma Collection System
Orthovita Receives CE Mark for VITAGEL(R) Surgical Hemostat and CELLPAKER(R) Plasma Collection System
HSMN NewsFeed - 30 Jul 2007
ThermoGenesis Corp. Appoints William Osgood Chief Executive Officer and Director
ThermoGenesis Corp. Appoints William Osgood Chief Executive Officer and Director
HSMN NewsFeed - 20 Jul 2007
Auriga Laboratories Appoints Lisa Tripodi as Vice President of Trade Relations
Auriga Laboratories Appoints Lisa Tripodi as Vice President of Trade Relations
HSMN NewsFeed - 2 Jul 2007
The Medicines Company Reacquires Angiox(R) (Bivalirudin) Rights in Europe from Nycomed
The Medicines Company Reacquires Angiox(R) (Bivalirudin) Rights in Europe from Nycomed
HSMN NewsFeed - 26 Jun 2007
Nuvelo Resumes Development of Alfimeprase in Multiple Blood-Clot Related Indications
Nuvelo Resumes Development of Alfimeprase in Multiple Blood-Clot Related Indications
HSMN NewsFeed - 21 Jun 2007
King Pharmaceuticals Announces FDA Approval of Epistaxis Kit for THROMBIN-JMI(R)
King Pharmaceuticals Announces FDA Approval of Epistaxis Kit for THROMBIN-JMI(R)
HSMN NewsFeed - 3 Jun 2007
Xeloda(R) Plus Avastin(R) Combination Delays Disease Progression in Women with Advanced Breast Cancer
Xeloda(R) Plus Avastin(R) Combination Delays Disease Progression in Women with Advanced Breast Cancer
HSMN NewsFeed - 2 Jun 2007
Biweekly Xeloda(R) Dosing Regimen is Well Tolerated in Advanced Breast Cancer
Biweekly Xeloda(R) Dosing Regimen is Well Tolerated in Advanced Breast Cancer
HSMN NewsFeed - 30 May 2007
Canadian Health Authority Approves THELIN (Sitaxsentan Sodium) for Pulmonary Arterial Hypertension
Canadian Health Authority Approves THELIN (Sitaxsentan Sodium) for Pulmonary Arterial Hypertension
HSMN NewsFeed - 16 Apr 2007
Encysive Pharmaceuticals Announces Launch of THELIN (Sitaxentan Sodium) in the Netherlands
Encysive Pharmaceuticals Announces Launch of THELIN (Sitaxentan Sodium) in the Netherlands
HSMN NewsFeed - 2 Apr 2007
Encysive Pharmaceuticals Announces Launch of Thelin (Sitaxentan Sodium) in Republic of Ireland
Encysive Pharmaceuticals Announces Launch of Thelin (Sitaxentan Sodium) in Republic of Ireland
HSMN NewsFeed - 24 Mar 2007
Schering-Plough's Novel Oral Thrombin Receptor Antagonist Meets Primary Endpoint in Phase II Trial
Schering-Plough's Novel Oral Thrombin Receptor Antagonist Meets Primary Endpoint in Phase II Trial
HSMN NewsFeed - 13 Mar 2007
GTC Biotherapeutics Grants Expanded License to PharmAthene for Further Development of Protexia(R)
GTC Biotherapeutics Grants Expanded License to PharmAthene for Further Development of Protexia(R)
HSMN NewsFeed - 3 Jan 2007
ThermoGenesis Corp. Appoints Industry Veteran William Osgood as General Manager of Operations
ThermoGenesis Corp. Appoints Industry Veteran William Osgood as General Manager of Operations
HSMN NewsFeed - 2 Jan 2007
Hospitals, Healthcare Providers to Save with Premier Plasma Distribution Agreement with FFF Enterprises
Hospitals, Healthcare Providers to Save with Premier Plasma Distribution Agreement with FFF Enterprises
HSMN NewsFeed - 26 Dec 2006
Vascular Solutions Announces Approval of 'Pocket Protector' Indication for D-Stat Flowable Hemostat
Vascular Solutions Announces Approval of 'Pocket Protector' Indication for D-Stat Flowable Hemostat
HSMN NewsFeed - 15 Dec 2006
Xeloda(R) Plus Avastin(R) Combination May Produce Clinical Benefit in Patients with Advanced Breast Cancer
Xeloda(R) Plus Avastin(R) Combination May Produce Clinical Benefit in Patients with Advanced Breast Cancer
HSMN NewsFeed - 11 Dec 2006
Xeloda(R) Combination Meets Primary Endpoint in International Phase III Advanced Colorectal Cancer Study
Xeloda(R) Combination Meets Primary Endpoint in International Phase III Advanced Colorectal Cancer Study
HSMN NewsFeed - 22 Nov 2006
The New England Journal of Medicine Publishes Angiomax(R) (Bivalirudin) ACUITY Trial Results
The New England Journal of Medicine Publishes Angiomax(R) (Bivalirudin) ACUITY Trial Results
HSMN NewsFeed - 1 Nov 2006
MediciNova Announces the Acquisition of Two Novel Antithrombotic Agents from Meiji Seika Kaisha, Ltd.
MediciNova Announces the Acquisition of Two Novel Antithrombotic Agents from Meiji Seika Kaisha, Ltd.
HSMN NewsFeed - 16 Oct 2006
OMRIX Biopharmaceuticals Announces Positive Phase 3 Clinical Trial Results for Human Thrombin
OMRIX Biopharmaceuticals Announces Positive Phase 3 Clinical Trial Results for Human Thrombin
HSMN NewsFeed - 11 Oct 2006
Vascular Solutions Announces Expanded Indications For D-Stat Dry Hemostatic Bandage
Vascular Solutions Announces Expanded Indications For D-Stat Dry Hemostatic Bandage
HSMN NewsFeed - 11 Jul 2006
Gentium Announces Publication of Two Independent Pediatric Studies of Defibrotide
Gentium Announces Publication of Two Independent Pediatric Studies of Defibrotide
HSMN NewsFeed - 6 Jul 2006
Nuvelo Announces Publication of Phase 2 Alfimeprase Study Results in Central Venous Catheter Occlusion
Nuvelo Announces Publication of Phase 2 Alfimeprase Study Results in Central Venous Catheter Occlusion
HSMN NewsFeed - 29 Jun 2006
Nuvelo Expands Depth in Manufacturing and Development With Key Additions to Management Team
Nuvelo Expands Depth in Manufacturing and Development With Key Additions to Management Team
HSMN NewsFeed - 26 Jun 2006
Enrollment in Phase III Clinical Trial for OMRIX's Thrombin Stand-Alone Product Has Been Completed
Enrollment in Phase III Clinical Trial for OMRIX's Thrombin Stand-Alone Product Has Been Completed
HSMN NewsFeed - 20 Jun 2006
Vascular Solutions Receives Conditional Approval to Commence Thrombin Clinical Study
Vascular Solutions Receives Conditional Approval to Commence Thrombin Clinical Study
HSMN NewsFeed - 16 Jun 2006
Orthovita Receives FDA Approval to Market Its VITAGEL(TM) Surgical Hemostat
Orthovita Receives FDA Approval to Market Its VITAGEL(TM) Surgical Hemostat
HSMN NewsFeed - 5 Jun 2006
Xeloda(R) Plus Cisplatin Combination Effective in Patients with Advanced Gastric Cancer
Xeloda(R) Plus Cisplatin Combination Effective in Patients with Advanced Gastric Cancer
HSMN NewsFeed - 31 May 2006
ThermoGenesis & NETCORD Note U.S. Patent Office's Rejection of PharmaStem Cord Blood Stem Cell Patent Claims
ThermoGenesis & NETCORD Note U.S. Patent Office's Rejection of PharmaStem Cord Blood Stem Cell Patent Claims
HSMN NewsFeed - 23 May 2006
Recruitment Planned to Resume in AVANT International Phase III Trial in Adjuvant Colon Cancer
Recruitment Planned to Resume in AVANT International Phase III Trial in Adjuvant Colon Cancer
HSMN NewsFeed - 3 May 2006
ZymoGenetics Names Vaughn Himes Senior Vice President of Technical Operations
ZymoGenetics Names Vaughn Himes Senior Vice President of Technical Operations
HSMN NewsFeed - 25 Apr 2006
ZymoGenetics Names Michael Dwyer Senior Vice President of Marketing and Sales
ZymoGenetics Names Michael Dwyer Senior Vice President of Marketing and Sales
HSMN NewsFeed - 19 Apr 2006
FDA Grants Fast Track Designation to Schering-Plough for its Thrombin Receptor Antagonist SCH 530348
FDA Grants Fast Track Designation to Schering-Plough for its Thrombin Receptor Antagonist SCH 530348
HSMN NewsFeed - 23 Mar 2006
Nuvelo Appoints Shelly D. Guyer Vice President, Business Development and Investor Relations
Nuvelo Appoints Shelly D. Guyer Vice President, Business Development and Investor Relations
HSMN NewsFeed - 24 Feb 2006
Premier's New Plasma and Recombinant Program Helps Hospitals Acquire Products in Short Supply
Premier's New Plasma and Recombinant Program Helps Hospitals Acquire Products in Short Supply
HSMN NewsFeed - 14 Feb 2006
ThermoGenesis Receives Health Canada Regulatory License to Market the AutoXpress System (AXP(TM))
ThermoGenesis Receives Health Canada Regulatory License to Market the AutoXpress System (AXP(TM))
Additional items found! 150

Members Archive contains
150 additional stories matching:
Thrombin
(Password required)
Thrombin
(Password required)